GALECTIN THERAPEUTICS INC Quarterly Interest Expense in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galectin Therapeutics Inc quarterly/annual Interest Expense history and growth rate from Q1 2018 to Q1 2024.
  • Galectin Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.05M, a 129% increase year-over-year.
  • Galectin Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $3.38M, a 167% increase year-over-year.
  • Galectin Therapeutics Inc annual Interest Expense for 2023 was $2.79M, a 170% increase from 2022.
  • Galectin Therapeutics Inc annual Interest Expense for 2022 was $1.03M, a 111% increase from 2021.
  • Galectin Therapeutics Inc annual Interest Expense for 2021 was $489K, a 462% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.38M $1.05M +$592K +129% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.79M $847K +$539K +175% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.25M $835K +$566K +210% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.69M $650K +$421K +184% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.27M $460K +$233K +103% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.03M $308K +$37K +13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $996K $269K +$158K +142% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $838K $229K +$144K +169% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $694K $227K +$205K +932% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $489K $271K +$249K +1132% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $240K $111K +$89K +405% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $151K $85K +$64K +305% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $87K $22K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $87K $22K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $87K $22K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $87K $21K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $87K $22K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $87K $22K -$58K -72.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $145K $22K -$65K -74.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $210K $21K -$64K -75.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $274K $22K -$62K -73.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $336K $80K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $87K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $85K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $84K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.